comparemela.com

Latest Breaking News On - Source sk life science inc - Page 1 : comparemela.com

SK Life Science Publishes Updated Real-World Experience on Cenobamate in Epilepsia Based on Recent 100,000 Patient Exposure Milestone

/PRNewswire/ SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous.

United kingdomUnited statesDexcel pharmaAngelini pharmaLouis ferrariWilliame rosenfeldMarc kaminSk life science incEuropean unionSk biopharmaceuticals co ltdSk life science labDrug administrationSk incSk groupEndo internationalSource sk life science inc

SK Life Science to Host Symposium and Present New Data at the American Epilepsy Society (AES) 2023 Annual Meeting

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and oncology, will present data on cenobamate at the American Epilepsy Society (AES) Annual Meeting, to be held December 1-5, 2023, in Orlando, Florida.

United statesUnited kingdomGregory kraussDanielle beckerLouis ferrariAngelini pharmaPavel kleinPatrick kwanOrange county convention centerAtlantic epilepsy sleep centerJohns hopkins university school of medicinebaltimoreOhio state university wexner medical centerSk biopharmaceuticals co ltdEuropean unionDepartment of neuroscience central clinical schoolSk life science inc

Latest XCOPRI® (cenobamate tablets) CV Post-hoc Analysis Presented at the 75th American Academy of Neurology Annual Meeting

SK Life Science will present analysis of 2,131 patients taking cenobamate during Phase 2 and 3 trials showing sudden unexpected death in epilepsy (SUDEP) rate.

United statesUnited kingdomWilliame rosenfeldAngelini pharmaLouis ferrariDina albaneseSource sk life science incSk incSk biopharmaceuticals co ltdSk groupAmerican academy of neurologySk life science incEpilepsy foundationEpilepsy care centerEuropean unionPharmacological treatments

SK Life Science CEO, Donghoon Lee, Shares His Vision for the Company and Energizes Workforce Meeting in San Diego This Week

/PRNewswire/ Donghoon Lee, CEO of SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company.

San diegoUnited statesDonghoon leeSk life science incSk groupSk biopharmaceuticals co ltdSource sk life science incSk group incDrug administrationSk incSk life science

SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AES 2022 Annual Meeting

/PRNewswire/ SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing.

United statesUnited kingdomAngelini pharmaPrnewswire sk life science incSk groupSource sk life science incSk biopharmaceuticals co ltdAmerican epilepsy societyEpilepsy foundationSk incSk life science incEuropean unionSudden unexpected deathAnnual meetingResponder rates overOno pharmaceutical

vimarsana © 2020. All Rights Reserved.